The medicine is called Evusheld, and its effectiveness is waning dramatically because new Covid-19 subvariants are taking center stage, and the drug doesn’t neutralize all of them.
A large study today from Germany shows that kids and adolescents are at the same relative risk of experiencing COVID-19 symptoms 90 days or more after acute infection as adults are, according to findings in PLOS Medicine.
In March 2020, New York City’s hospitals filled up with patients desperately ill with Covid-19. In many cases, when their fluid-filled lungs could no longer give them oxygen, doctors sedated them and put them on ventilators.
The patients who recovered were taken off the machines and anesthesia. Within a day or so, their doctors expected them to wake up.
A pair of new studies describe how two US jurisdictions quickly mobilized teams of contact tracers to identify and isolate people exposed to SARS-CoV-2, with a massive New York City effort finding 1.4 contacts per case and a college student-led Central Pennsylvania initiative that may have led to fewer symptomatic household infections.
